Electrical faults and colonisation by micro-organisms are the two major causes of failure of implanted stimulator devices such as neurological prostheses, and the second of these causes of failure is one shared with other silicone rubber implant devices such as hydrocephalus shunts.'-3 Electrical failures can generally be repaired without much delay, ifthe implant is well-designed, but an infected implant must be removed, and it is our experience that a delay of at least 12 months must elapse before it can be replaced without fear of recrudescence of infection. Systemic antibiotic treatment ofinfection established around an implant is unsuccessful unless the implant is removed, because the potential space between the implant and the surrounding connective tissue or fibrous tissue encapsulation is relatively poorly reached both by systemic antibiotics and by body defences, and allows free spread of bacteria in the fluid film.
Of the first 35 devices designed in the MRC Neurological Prostheses Unit that were implanted into patients (February 1972 to December 1981), two became infected (5.7%). It seemed likely that the organisms causing colonisation were derived from the patient's skin and implanted at the time of operation, and that they were able to thrive and cause a serious infection because of their privileged position at the implant surface. It appeared that implant infections never occurred later, unless the implant was exposed for some reason; instances where this happened are discussed below.
For some implant types it has been shown' that systemic treatment with prophylactic antibiotics at the time of surgery can reduce the rate of implant infection, provided treatment is effective during a "decisive period" of 0-4 h after surgery. Systemic treatment requires relatively large doses to attain a bactericidal concentration at the implant surface, with a correspondingly increased risk of resistance, sideeffects and superinfections. These risks are clearly more weighty when an antibiotic is being given prophylactically rather than for an established infection. For some types of implant (notably hip replacements and cardiac pacemakers), systemic prophylaxis has been found to be effective in reducing implant infections by a factor of 356 to 7-7;4 short courses seem to be as effective as long ones.7 For hip replacements, gentamicin-impregnated bone cement has been shown to be significantly better even than a 224 sity used (and almost certainly effective), without a formal controlled trial having ever been undertaken.'"
We therefore considered ways of generating a bactericidal concentration of appropriate antibiotic at the site where it is required (in the potential space between implant and tissues), at the time when it is required (during the first few hours and days after implantation). Spraying with antibiotic powder during surgery may be effective for the parts ofthe implant that it can reach, but it cannot reach cables or tubes implanted by pulling through a cannula.
We sought a method for antibiotic impregnation of the surface layer of an implant, using agents that could withstand the processes of implant manufacture, storage and autoclaving, and which would diffuse out over a suitable period after implantation. Several methods have been described" for antibiotic impregnation of a heat-crosslinking rubber used in the manufacture of hydrocephalus shunts. Bayston and Milner showed that the method of physical preparation of the antibiotic and its mixing with the rubber was often crucial, that gentamicin sulphate, sodium and diethanolamine fusidates and clindamycin hydrochloride were stable through the manufacturing process for their rubbers, and that when immersed they diffused out with a bactericidal effect lasting for a relatively short (gentamicin) or a relatively prolonged (diethanolamine or sodium fusidate, clindamycin) period of in vitro testing.
Experience of hydrocephalus shunt infections is wide,'-3 and the commonest organism is there found to be Staphylococcus epidermidis followed by S. aureus and diphtheroids, and occasionally Proteus and Pseudomonas species. We are not aware of any published account of infecting organisms in neurostimulator implants, but our infections included the same list of organisms as for shunts, in the same order of frequency. We therefore chose a mixture of antimicrobial agents appropriate to the range of organisms likely to initiate infections. Fusidic acid is a specific antistaphylococcal agent with high activity and stability. Some resistance is known to occur, and this agent is only effective against Gram-positive bacteria, so we also included gentamicin sulphate in the coating. This is a broad-spectrum antibiotic, with high activity against most Gram-negative bacteria including Pseudomonas species. Gentamicin sulphate is highly heat-stable, but does show some loss of activity at low pH. It seemed likely that a coarse particulate form of gentamicin incorporated in the surface of the rubber would be most effective, since it had been shown that only incompletely incarcerated particles would be effective," whereas for diethanolamine fusidate the particle size mattered less, because the drug could diffuse through silicone rubber.
Rushton, Brindley, Polkey, Browning We chose to impregnate only a surface coating of silicone rubber applied to the implant after manufacture was otherwise complete, rather than the fullthickness method propsed by Bayston and Milner. There were several reasons for this. Firstly, admixing a coarse particulate preparation of antibiotic powder is likely to degrade the physical properties of the rubber, whose mechanical strength and electrical insulating properties are important.'2 Secondly, different parts of the implant are made in different ways at different times, so coating is simpler. Thirdly, since the diffusion of gentamicin in particular through rubber is so slow, antibiotic particles in the depths of the rubber would be ineffective. Lastly, whereas there is for shunts a need to protect the lumen as well as the outer surface,3 for stimulators there is no such need.
Methods in vitro
We used air-curing adhesive silicone rubbers, described by the manufacturers as ("medical adhesive" (Dow-Coming Type 891), 'adhesive/sealant" (Dow-Corning Type 734) or "coating" (Dow-Coming Type 3140). Heat or pressure are not required for their cure, but they all evolve either acetic acid (891, 734) or methanol (3140) in the curing process. It was therefore necesary to make in vitro tests of the antimicrobial effectiveness of implant samples coated with acid-or alcohol-evolving rubbers impregnated with one or both of gentamicin sulphate and diethanolamine fusidate.
Samples of implant cable, consisting of silicone rubber with a number of helically-wound insulated platinum or platinum-iridium conductors embedded in it ("Coopercable"; see ref 13) were coated with a layer of antibioticimpregnated rubber. The manufactured diameter of cables is 19 mm, and the thickness of the impregnated coating 0-125 mm, so that the final diameter is 2-15 mm. The impregnated rubber was prepared by mixing with a spatula 20 mg ofeither or both antibiotics with each 1 gram of liquid rubber, mixing quickly and thoroughly until it appeared uniform, and then applying it to the cable by hand using a split die.24 Using this method, particle size for gentamicin sulphate (Nicholas) was about 0001-001 mm, and for diethanolamine fusidate (Leo) about 0 01-002 mm. After air-curing the samples were stored for 1 week and then autoclaved in a steam autoclave (135°C for 5 mins), or else stored for 6 months and then autoclaved, before being tested for antibacterial activity.
Tests for antibacterial activity were carried out on lengths of cable of 1 cm or longer, placed onto petri dishes of Sensitivity Test agar (Lab M) supplemented with 5% lysed horse blood (TCS) previously seeded with suspensions of either Stapyhylococcus aureus NCTC 6571 or Escherichia coli NCTC 10418. Turbidity was standardised to a McFarland barium sulphate standard No 1. Some samples were tested after elution in still physiological saline at 37'C for 1, 3 and 7 days. Widths of zones of inhibition were measured after incubation for 18 h at 37'C. The width of the contact surface was narrower than the cable diameter, so the width recorded was the total width ofthe zone ofinhibition. All samples were tested in duplicate or more, and the zones were measured by Figure lc shows the widths ofzones of inhibition for the two antibiotics separately and together. There is no evidence of significant mutual interference. Figure 2a , b compares the zones of inhibition with and without autoclaving. For both antibiotics there is a slight diminution in activity, and this is not surprising as the water condensate which is formed in steam autoclaving would be expected to leach away some of the most accessible small antibiotic particles. Figure 2c shows the effect of 6 months aging at room temperature in a plastic box on the laboratory shelf, followed by steam autoclaving, compared with non-aged samples. There is no evidence of loss of activity with time alone. This test used alcohol-evolving rubber but there is no reason to expect that acid-evolving rubber would be any different, as all the acetic acid evaporates from a thin coating in a few hours. Rates of true postoperative implant infection Table 2 shows the implants remaining after making the above exclusions. The percentages ofinfections probably introduced at operation are 10-0% for uncoated implants and 0-7% for coated implants. This difference is highly significant (chi-square; p < 0-001). prophylaxis was 4/40 (10%), while for those without it was 4/37 (10-8%). This difference is also insignificant, and a much larger series would be required in order to detect any slight benefit there may be from systemic prophylaxis.
Discussion
The results show that antibiotic-impregnated silicone rubber coating of stimulator implant cables and Rushton, Brindley, Polkey, Browning
